General Information of Drug-Metabolizing Enzyme (DME ID: DME0414)
DME Name Short-chain dehydrogenase/reductase retSDR1 (DHRS3), Homo sapiens DME Info
UniProt ID
DHRS3_HUMAN
EC Number    EC: 1.1.1.300     (Click to Show/Hide the Complete EC Tree)
Oxidoreductase
CH-OH donor oxidoreductase
NAD/NADP oxidoreductase
EC: 1.1.1.300
Lineage    Species: Homo sapiens     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Interactome
Disease Specific Interactions between Host Protein and DME (HOSPPI)
      ICD Disease Classification Healthy
               ICD-11: Healthy Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Oligomerization
                            Retinol dehydrogenase 10 (RDH10) Health Homooligomer
Uniprot ID
RDH10_HUMAN
Interaction Name RDH10-DHRS3 homooligomerization [1]
Studied Cell Lines Human embryonic kidney cell line (HEK293)
Affected Substrate(s): Reduction of retinaldehyde (Metabolic product: Retinol)
Description Retinol dehydrogenase 10 (RDH10) is reported to homooligomerize with the DHRS3 protein, which leads to activation of the drug-metabolizing enzyme Short-chain dehydrogenase/reductase retSDR1. As a result, the interaction between RDH10 and DHRS3 can activate the drug-metabolizing process of Short-chain dehydrogenase/reductase retSDR1.
      ICD Disease Classification 02 Neoplasms
               ICD-11: 2B30 Lymphoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Lymphoma Significant hypermethylation
Interaction Name DNMT-DHRS3 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypermethylation
p-value: 3.33E-09; delta-beta: 3.29E-01
Description DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the DHRS3 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Short-chain dehydrogenase/reductase retSDR1. As a result, the interaction between DNMT and DHRS3 can significantly affect the drug-metabolizing process of Short-chain dehydrogenase/reductase retSDR1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
References
1 The antagonistically bifunctional retinoid oxidoreductase complex is required for maintenance of all-trans-retinoic acid homeostasis. J Biol Chem. 2017 Apr 7;292(14):5884-5897.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.